178 related articles for article (PubMed ID: 2555551)
21. Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas.
Boerkoel CF; Kung HJ
J Virol; 1992 Aug; 66(8):4814-23. PubMed ID: 1321271
[TBL] [Abstract][Full Text] [Related]
22. Novel retroviral vectors for efficient expression of the multidrug resistance (mdr-1) gene in early hematopoietic cells.
Baum C; Hegewisch-Becker S; Eckert HG; Stocking C; Ostertag W
J Virol; 1995 Dec; 69(12):7541-7. PubMed ID: 7494260
[TBL] [Abstract][Full Text] [Related]
23. Localization of the leukemogenic determinants of SL3-3, an ecotropic, XC-positive murine leukemia virus of AKR mouse origin.
Lenz J; Haseltine WA
J Virol; 1983 Aug; 47(2):317-28. PubMed ID: 6312068
[TBL] [Abstract][Full Text] [Related]
24. Involvement of nuclear factor I-binding sites in control of Akv virus gene expression.
Olsen HS; Lovmand S; Lovmand J; Jørgensen P; Kjeldgaard NO; Pedersen FS
J Virol; 1990 Sep; 64(9):4152-61. PubMed ID: 2166811
[TBL] [Abstract][Full Text] [Related]
25. Virological events leading to spontaneous AKR thymomas.
Stoye JP; Moroni C; Coffin JM
J Virol; 1991 Mar; 65(3):1273-85. PubMed ID: 1847454
[TBL] [Abstract][Full Text] [Related]
26. B-Cell lymphoma induction by akv murine leukemia viruses harboring one or both copies of the tandem repeat in the U3 enhancer.
Lovmand J; Sorensen AB; Schmidt J; Ostergaard M; Luz A; Pedersen FS
J Virol; 1998 Jul; 72(7):5745-56. PubMed ID: 9621033
[TBL] [Abstract][Full Text] [Related]
27. Stability of AML1 (core) site enhancer mutations in T lymphomas induced by attenuated SL3-3 murine leukemia virus mutants.
Amtoft HW; Sørensen AB; Bareil C; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Jul; 71(7):5080-7. PubMed ID: 9188573
[TBL] [Abstract][Full Text] [Related]
28. E- vectors: development of novel self-inactivating and self-activating retroviral vectors for safer gene therapy.
Julias JG; Hash D; Pathak VK
J Virol; 1995 Nov; 69(11):6839-46. PubMed ID: 7474097
[TBL] [Abstract][Full Text] [Related]
29. Ectopic expression of the erythrocyte band 3 anion exchange protein, using a new avian retrovirus vector.
Fuerstenberg S; Beug H; Introna M; Khazaie K; Muñoz A; Ness S; Nordström K; Sap J; Stanley I; Zenke M
J Virol; 1990 Dec; 64(12):5891-902. PubMed ID: 2173771
[TBL] [Abstract][Full Text] [Related]
30. An MuLV transmission vector system designed to permit recovery in E. coli of proviral and cellular flanking sequences.
Jørgensen P; Mikkelsen T; Pedersen FS; Kjeldgaard NO
Virus Genes; 1988 Mar; 1(2):221-33. PubMed ID: 2467437
[TBL] [Abstract][Full Text] [Related]
31. Analysis of the relative level of gene expression from different retroviral vectors used for gene therapy.
Byun J; Kim SH; Kim JM; Yu SS; Robbins PD; Yim J; Kim S
Gene Ther; 1996 Sep; 3(9):780-8. PubMed ID: 8875226
[TBL] [Abstract][Full Text] [Related]
32. Glucocorticoid regulation of murine leukemia virus transcription elements is specified by determinants within the viral enhancer region.
Celander D; Haseltine WA
J Virol; 1987 Feb; 61(2):269-75. PubMed ID: 3027359
[TBL] [Abstract][Full Text] [Related]
33. The secondary structure of the R region of a murine leukemia virus is important for stimulation of long terminal repeat-driven gene expression.
Cupelli L; Okenquist SA; Trubetskoy A; Lenz J
J Virol; 1998 Oct; 72(10):7807-14. PubMed ID: 9733816
[TBL] [Abstract][Full Text] [Related]
34. Increased lymphomagenicity and restored disease specificity of AML1 site (core) mutant SL3-3 murine leukemia virus by a second-site enhancer variant evolved in vivo.
Ethelberg S; Lovmand J; Schmidt J; Luz A; Pedersen FS
J Virol; 1997 Oct; 71(10):7273-80. PubMed ID: 9311802
[TBL] [Abstract][Full Text] [Related]
35. A nonproducer, interfering human immunodeficiency virus (HIV) type 1 provirus can be transduced through a murine leukemia virus-based retroviral vector: recovery of an anti-HIV mouse/human pseudotype retrovirus.
Federico M; Nappi F; Ferrari G; Chelucci C; Mavilio F; Verani P
J Virol; 1995 Nov; 69(11):6618-26. PubMed ID: 7474070
[TBL] [Abstract][Full Text] [Related]
36. Pathogenic determinants in the U3 region of recombinant murine leukemia viruses isolated from CWD and HRS/J mice.
Lawrenz-Smith SC; Massey AC; Innes DJ; Thomas CY
J Virol; 1994 Aug; 68(8):5174-83. PubMed ID: 8035516
[TBL] [Abstract][Full Text] [Related]
37. U3 long terminal repeat-mediated induction of intracellular immunity by a murine retrovirus: a novel model of latency for retroviruses.
Gorska-Flipot I; Huang M; Cantin M; Rassart E; Massé G; Jolicoeur P
J Virol; 1992 Dec; 66(12):7201-10. PubMed ID: 1433513
[TBL] [Abstract][Full Text] [Related]
38. Mechanism of selection of class II recombinant murine leukemia viruses in the highly leukemic strain CWD.
Thomas CY; Roberts JS; Buxton VK
J Virol; 1988 Apr; 62(4):1158-66. PubMed ID: 2831378
[TBL] [Abstract][Full Text] [Related]
39. An enhancer sequence instability that diversifies the cell repertoire for expression of a murine leukemia virus.
Spiro C; Li JP; Bestwick RK; Kabat D
Virology; 1988 Jun; 164(2):350-61. PubMed ID: 2835856
[TBL] [Abstract][Full Text] [Related]
40. Tagging the genome of the murine leukemia retrovirus SL3-3 by a bacterial lac operator sequence.
Jørgensen P; Mikkelsen T; Pedersen K; Pedersen FS; Kjeldgaard NO
Gene; 1991 Dec; 109(2):243-7. PubMed ID: 1722473
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
